Clinically, HSP70 level is correlated with AR and AR-V7 in high Gleason score prostate tumors, suggesting that HSP70 might serve as a potential marker to indicate prostate cancer progression and therapeutic resistance. The gene discussed is HSPA1A; the disease is prostate neoplasm.